Open AccessThe Use of Rifapentine for Preventive Chemotherapy in Children from Risk Groups of Developing Tuberculosis
Author(s) -
О. Д. Баронова,
Valentina Aksenova,
Е. Ф. Лугинова,
E. N. Dolzhenko
Publication year - 2022
Publication title -
tuberkulez i bolezni lëgkih/tuberkulëz i bolezni lëgkih
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.226
H-Index - 12
eISSN - 2542-1506
pISSN - 2075-1230
DOI - 10.21292/2075-1230-2022-100-8-31-36
Subject(s) - rifapentine , isoniazid , medicine , latent tuberculosis , regimen , mcnemar's test , rifampicin , tuberculosis , chemotherapy , adverse effect , pediatrics , mycobacterium tuberculosis , pathology , statistics , mathematics